Arthur J. Kudla
- Molecular Biology top 10%
- Oncology top 10%
- Radiology, Nuclear Medicine and Imaging top 5%
- Cardiology and Cardiovascular Medicine
- Cell Biology
- Co-authors
- Stephen F. KoniecznyYanfeng KongMatthew J. FlickViolette ParagasBradley B. OlwinUlrik B. NielsenNeeraj KohliMichael J. Feldhaus
- Topics
- HER2/EGFR in Cancer Research (12 papers)Monoclonal and Polyclonal Antibodies Research (10 papers)Multiple Myeloma Research and Treatments (5 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Arthur J. Kudla
27 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 88
- Molecular Biology 782
- Oncology 416
- Radiology, Nuclear Medicine and Imaging 376
- Cardiology and Cardiovascular Medicine 107
- Cell Biology 91
Countries citing papers authored by Arthur J. Kudla
This map shows the geographic impact of Arthur J. Kudla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arthur J. Kudla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arthur J. Kudla more than expected).
Fields of papers citing papers by Arthur J. Kudla
This network shows the impact of papers produced by Arthur J. Kudla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arthur J. Kudla. The network helps show where Arthur J. Kudla may publish in the future.
Co-authorship network of co-authors of Arthur J. Kudla
This figure shows the co-authorship network connecting the top 25 collaborators of Arthur J. Kudla. A scholar is included among the top collaborators of Arthur J. Kudla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arthur J. Kudla. Arthur J. Kudla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 11 | |
| 3 | 16 | |
| 4 | 10 | |
| 5 | 6 | |
| 6 | 72 | |
| 7 | 3 | |
| 8 | 9 | |
| 9 | 222 | |
| 10 | 3 | |
| 11 | 1 | |
| 12 | 4 | |
| 13 | 275 | |
| 14 | 32 | |
| 15 | 33 | |
| 16 | 234 | |
| 17 | 11 | |
| 18 | 35 | |
| 19 | 59 | |
| 20 | 38 |
About Arthur J. Kudla
Arthur J. Kudla is a scholar working on Oncology, Hematology and Radiology, Nuclear Medicine and Imaging, having authored 27 papers that have together received 1.2k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (12 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Multiple Myeloma Research and Treatments (5 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (376 citations), Oncology (416 citations) and Molecular Biology (782 citations). Arthur J. Kudla has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Stephen F. Konieczny, Yanfeng Kong, Matthew J. Flick, Violette Paragas, Bradley B. Olwin, Ulrik B. Nielsen, Neeraj Kohli, Michael J. Feldhaus, Birgit Schoeberl and Brian D. Harms. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.